Drugs / PAMVAC
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02647489 | May 2016 → Nov 2017 | malaria | University Hospital Tuebingen | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PAMVAC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02647489 ↗ |
| Modality | Protein / enzyme biologic | “The PAMVAC vaccine is a VAR2CSA protein-based vaccine” NCT02647489 ↗ |